SCHEMBL9944783

SCHEMBL9944783

CNc1cc(N(C)CC(N)=O)c(C(=O)N[C@H]2CC[C@H](C)CC2)cc1[N+](=O)[O-]

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.40
RAB9A P51151 4/20 0.39
NPC1 O15118 3/20 0.39
TAS1R3 Q7RTX0 2/20 0.36
TAS1R1 Q7RTX1 2/20 0.36
TAS1R2 Q8TE23 2/20 0.36
CNR2 P34972 5/20 0.35
PTGES O14684 1/20 0.35
CNR1 P21554 4/20 0.34
MLNR O43193 1/20 0.33
ADRB2 P07550 1/20 0.33
CHRM1 P11229 1/20 0.33
DRD2 P14416 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
CHRM3 P20309 1/20 0.33
SLC6A2 P23975 1/20 0.33
HTR2A P28223 1/20 0.33
SLC6A4 P31645 1/20 0.33
HRH1 P35367 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9899009 0.89 PTGES (0.45) ALDH1A1PTGESMLNRADRB2CHRM1
SCHEMBL9899013 0.89 PTGES (0.45) ALDH1A1PTGESMLNRADRB2CHRM1
SCHEMBL9944785 0.86 ALDH1A1 (0.40) ALDH1A1RAB9ANPC1TAS1R3TAS1R1
SCHEMBL9944933 0.86 ALDH1A1 (0.40) ALDH1A1RAB9ANPC1TAS1R3TAS1R1
SCHEMBL9944779 0.86 ALDH1A1 (0.40) ALDH1A1RAB9ANPC1TAS1R3TAS1R1
SCHEMBL9944927 0.86 ALDH1A1 (0.40) ALDH1A1RAB9ANPC1TAS1R3TAS1R1
SCHEMBL9944935 0.85 RAB9A (0.43) RAB9ANPC1TAS1R3TAS1R1TAS1R2
SCHEMBL9944929 0.85 ALDH1A1 (0.39) ALDH1A1RAB9ANPC1TAS1R3TAS1R1
SCHEMBL9944925 0.84 ALDH1A1 (0.39) ALDH1A1RAB9ANPC1TAS1R3TAS1R1
SCHEMBL9944924 0.83 ALDH1A1 (0.38) ALDH1A1RAB9ANPC1TAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8674113-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-03-18 US disclosed
US-20120149676-A1 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149676-A1 NOVEL COMPOUNDS PTGS1, PTGER1, PTGES ALDH1A1 126/4885RAB9A 1033/4885NPC1 1695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.